220 related articles for article (PubMed ID: 31429685)
21. Intradermal and intranasal immunizations with oligomeric middle layer rotavirus VP6 induce Th1, Th2 and Th17 T cell subsets and CD4
Heinimäki S; Malm M; Vesikari T; Blazevic V
Antiviral Res; 2018 Sep; 157():1-8. PubMed ID: 29935205
[TBL] [Abstract][Full Text] [Related]
22. Engineering and expression of a human rotavirus candidate vaccine in Nicotiana benthamiana.
Pêra FF; Mutepfa DL; Khan AM; Els JH; Mbewana S; van Dijk AA; Rybicki EP; Hitzeroth II
Virol J; 2015 Dec; 12():205. PubMed ID: 26626122
[TBL] [Abstract][Full Text] [Related]
23. Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein.
Choi AH; Basu M; McNeal MM; Clements JD; Ward RL
J Virol; 1999 Sep; 73(9):7574-81. PubMed ID: 10438847
[TBL] [Abstract][Full Text] [Related]
24. [A fusion protein of rotavirus VP6 and cholera toxin B subunit: expression in Escherichia coli and analysis of biological activities].
Guo TX; Fang RX; Li GH; Qian Y
Sheng Wu Gong Cheng Xue Bao; 2001 Nov; 17(6):621-5. PubMed ID: 11910752
[TBL] [Abstract][Full Text] [Related]
25. Homotypic protection against rotavirus-induced diarrhea in infant mice breast-fed by dams immunized with the recombinant VP8* subunit of the VP4 capsid protein.
Gil MT; de Souza CO; Asensi M; Buesa J
Viral Immunol; 2000; 13(2):187-200. PubMed ID: 10892999
[TBL] [Abstract][Full Text] [Related]
26. [Expression of the main structural antigen VP6 of human rotavirus by recombinant adenovirus and immune responses induced in vivo].
He J; Wang J; Jiang X; Wang D; Wen L; Dong J; Qu J; Hong T
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun; 16(2):109-13. PubMed ID: 12196818
[TBL] [Abstract][Full Text] [Related]
27. A new rotavirus VP6-based foreign epitope presenting vector and immunoreactivity of VP4 epitope chimeric proteins.
Teng Y; Zhao B; Pan X; Wen Y; Chen Y
Viral Immunol; 2014 Apr; 27(3):96-104. PubMed ID: 24702286
[TBL] [Abstract][Full Text] [Related]
28. Rotavirus capsid VP6 tubular and spherical nanostructures act as local adjuvants when co-delivered with norovirus VLPs.
Malm M; Heinimäki S; Vesikari T; Blazevic V
Clin Exp Immunol; 2017 Sep; 189(3):331-341. PubMed ID: 28407442
[TBL] [Abstract][Full Text] [Related]
29. Highly sensitive ELISA for the serological detection of murine rotavirus EDIM based on its major immunogen VP6.
Fingas F; Rückner A; Heenemann K; Volke D; Sieg M; Bielefeldt P; Grunwald T; Vahlenkamp TW; Hassert R; Hoffmann R
J Virol Methods; 2018 Dec; 262():72-78. PubMed ID: 30144945
[TBL] [Abstract][Full Text] [Related]
30. Protective efficacy of rotavirus 2/6-virus-like particles combined with CT-E29H, a detoxified cholera toxin adjuvant.
Siadat-Pajouh M; Cai L
Viral Immunol; 2001; 14(1):31-47. PubMed ID: 11270595
[TBL] [Abstract][Full Text] [Related]
31. Mice develop effective but delayed protective immune responses when immunized as neonates either intranasally with nonliving VP6/LT(R192G) or orally with live rhesus rotavirus vaccine candidates.
VanCott JL; Prada AE; McNeal MM; Stone SC; Basu M; Huffer B; Smiley KL; Shao M; Bean JA; Clements JD; Choi AH; Ward RL
J Virol; 2006 May; 80(10):4949-61. PubMed ID: 16641286
[TBL] [Abstract][Full Text] [Related]
32. Association of gamma interferon and interleukin-17 production in intestinal CD4+ T cells with protection against rotavirus shedding in mice intranasally immunized with VP6 and the adjuvant LT(R192G).
Smiley KL; McNeal MM; Basu M; Choi AH; Clements JD; Ward RL
J Virol; 2007 Apr; 81(8):3740-8. PubMed ID: 17251301
[TBL] [Abstract][Full Text] [Related]
33. Particle bombardment-mediated DNA vaccination with rotavirus VP6 induces high levels of serum rotavirus IgG but fails to protect mice against challenge.
Choi AH; Knowlton DR; McNeal MM; Ward RL
Virology; 1997 May; 232(1):129-38. PubMed ID: 9185596
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and characterization of different immunogenic viral nanoconstructs from rotavirus VP6 inner capsid protein.
Bugli F; Caprettini V; Cacaci M; Martini C; Paroni Sterbini F; Torelli R; Della Longa S; Papi M; Palmieri V; Giardina B; Posteraro B; Sanguinetti M; Arcovito A
Int J Nanomedicine; 2014; 9():2727-39. PubMed ID: 24936129
[TBL] [Abstract][Full Text] [Related]
35. Rotavirus VP6 as a potential vaccine candidate.
Afchangi A; Jalilvand S; Mohajel N; Marashi SM; Shoja Z
Rev Med Virol; 2019 Mar; 29(2):e2027. PubMed ID: 30614135
[TBL] [Abstract][Full Text] [Related]
36. Prime immunization with rotavirus VLP 2/6 followed by boosting with an adenovirus expressing VP6 induces protective immunization against rotavirus in mice.
Zhou H; Guo L; Wang M; Qu J; Zhao Z; Wang J; Hung T
Virol J; 2011 Jan; 8():3. PubMed ID: 21205330
[TBL] [Abstract][Full Text] [Related]
37. Oral administration of plant-based rotavirus VP6 induces antigen-specific IgAs, IgGs and passive protection in mice.
Zhou B; Zhang Y; Wang X; Dong J; Wang B; Han C; Yu J; Li D
Vaccine; 2010 Aug; 28(37):6021-7. PubMed ID: 20637305
[TBL] [Abstract][Full Text] [Related]
38. Recombinant monovalent llama-derived antibody fragments (VHH) to rotavirus VP6 protect neonatal gnotobiotic piglets against human rotavirus-induced diarrhea.
Vega CG; Bok M; Vlasova AN; Chattha KS; Gómez-Sebastián S; Nuñez C; Alvarado C; Lasa R; Escribano JM; Garaicoechea LL; Fernandez F; Bok K; Wigdorovitz A; Saif LJ; Parreño V
PLoS Pathog; 2013; 9(5):e1003334. PubMed ID: 23658521
[TBL] [Abstract][Full Text] [Related]
39. Expression of human rotavirus chimeric fusion proteins from replicating but non disseminating adenovectors and elicitation of rotavirus-specific immune responses in mice.
Girard A; Roques E; St-Louis MC; Massie B; Archambault D
Mol Biotechnol; 2013 Jul; 54(3):1010-20. PubMed ID: 23430460
[TBL] [Abstract][Full Text] [Related]
40. [Expression of recombinant Vp6 gene of porcine rotavirus A with non-antibiotic Lactobacillus vector in Escherichia coli].
Wang CF; Cong YL; Liu SG; Li Y
Wei Sheng Wu Xue Bao; 2005 Oct; 45(5):685-9. PubMed ID: 16342756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
